Handelsbanken Fonder’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-51,504
Closed -$109K 1673
2022
Q1
$109K Hold
51,504
﹤0.01% 1684
2021
Q4
$191K Buy
51,504
+37,900
+279% +$163K ﹤0.01% 1712
2021
Q3
$68K Hold
13,604
﹤0.01% 1674
2021
Q2
$89K Sell
13,604
-1,200
-8% -$8.38K ﹤0.01% 1704
2021
Q1
$102K Hold
14,804
﹤0.01% 1557
2020
Q4
$151K Hold
14,804
﹤0.01% 1537
2020
Q3
$52K Hold
14,804
﹤0.01% 1450
2020
Q2
$74K Buy
+14,804
New +$50.4K ﹤0.01% 1431

Other funds holding PGEN

Handelsbanken Fonder's PGEN Position: Q2 2022 in Review

Handelsbanken Fonder sold out of Precigen (PGEN) in Q2 2022, closing a stake of 51,504 shares — an estimated $109K sold.

Handelsbanken Fonder first reported a position in PGEN in Q2 2020 and held it in 8 quarters. The position peaked at $191K in Q4 2021. 169 funds tracked by Wall St. Rank hold PGEN as of Q2 2022.

  • Handelsbanken Fonder reported no remaining Precigen position as of Q2 2022 after selling out during the quarter.
  • Handelsbanken Fonder sold 51,504 Precigen shares in Q2 2022, an estimated $109K.
  • Handelsbanken Fonder first reported a position in Precigen in Q2 2020 and held it in 8 quarters.
  • Handelsbanken Fonder's Precigen position peaked at $191K in Q4 2021.
  • 169 funds tracked by Wall St. Rank held Precigen as of Q2 2022.

Based on Handelsbanken Fonder's 13F filing for Q2 2022, filed 3 Aug 2022.